Electroanatomical Mapping of Patients Undergoing Catheter Ablation Procedures Using Rhythmia Mapping System and Catheter
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
London, Ontario, Canada
- London Health Sciences Centre
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient understands the implications of participating in the study and provides informed consent
- Patient is willing to comply with specified follow-up evaluation and can be contacted by telephone
- Patients referred for a catheter ablation procedure to treat an atrial or ventricular arrhythmia
- Patient can be heparinized during the procedure
Exclusion Criteria:
- Patients requiring an emergency ablation procedure
- Patients hemodynamically unstable
- Patients with NYHA Class III or IV heart failure
- Women who are pregnant or lactating
- Patients having cardiac surgery within the past two months
- Patients with Long QT Syndrome, Brugada Syndrome, or Torsade de Pointes
- Patients with intracardiac thrombus, tumor, or other abnormality which precludes catheter introduction
- Patients with acute myocardial infarction within 3 months
- Patients awaiting cardiac transplantation
- Patients enrolled in any other clinical study
- Patients with an age <18 or >75 years
- Patients with stable/unstable angina or ongoing myocardial ischemia
- Patients with congenital heart disease (not including atrial septal defect (ASD) or patent foramen ovale (PFO) without a right to left shunt) where the underlying abnormality increases the risk of an ablative procedure
- Patients with pulmonary hypertension (mean or systolic pulmonary artery (PA) pressure > 50mm Hg on Doppler echo)
- Patients with a left atrial diameter > 55 mm
- Patients with any arrhythmia currently being treated where the arrhythmia or the management may interfere with this study
- Patients with active infection or sepsis
- Patients with untreatable allergy to contrast media
- Patients with a history of blood clotting (bleeding or thrombotic) abnormalities
- Patients with any known sensitivities to heparin or warfarin
- Patients with severe chronic obstructive pulmonary disease (COPD) (identified by a forced expiratory volume [FEV1] <1)
- Patients with severe co morbidity or poor general physical/mental health that, in the opinion of the investigator, will not allow the patient to be a good study candidate (i.e. other disease processes, mental capacity, substance abuse, shortened life expectance, etc.)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Rhythmia Mapping System & Catheter
This is a single arm diagnostic feasibility study with the Rhythmia Mapping System and the Rhythmia Mapping Catheter
|
Patients will undergo a diagnostic assessment with the Rhythmia Mapping System and the Rhythmia Mapping Catheter as part of the Electrophysiology Ablation Procedure.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Major device related adverse cardiac and cerebrovascular events
Time Frame: 30 days
|
30 days
|
|
Device Performance
Time Frame: 1 day- Procedure
|
1 day- Procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- TP000-147
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.